These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 37846582)

  • 1. Towards more accurate pharmacogenomic variant effect predictions.
    Park Y; Lauschke VM
    Pharmacogenomics; 2023 Nov; 24(16):841-844. PubMed ID: 37846582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. APF2: an improved ensemble method for pharmacogenomic variant effect prediction.
    Zhou Y; Pirmann S; Lauschke VM
    Pharmacogenomics J; 2024 May; 24(3):17. PubMed ID: 38802404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of the PGx-Passport: A Panel of Actionable Germline Genetic Variants for Pre-Emptive Pharmacogenetic Testing.
    van der Wouden CH; van Rhenen MH; Jama WOM; Ingelman-Sundberg M; Lauschke VM; Konta L; Schwab M; Swen JJ; Guchelaar HJ
    Clin Pharmacol Ther; 2019 Oct; 106(4):866-873. PubMed ID: 31038729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychiatric Pharmacogenomics: How to Integrate into Clinical Practice.
    Stahl SM
    CNS Spectr; 2017 Feb; 22(1):1-4. PubMed ID: 28168945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Translating pharmacogenomic sequencing data into drug response predictions-How to interpret variants of unknown significance.
    Tremmel R; Pirmann S; Zhou Y; Lauschke VM
    Br J Clin Pharmacol; 2023 Sep; ():. PubMed ID: 37759374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Translating genotype data of 44,000 biobank participants into clinical pharmacogenetic recommendations: challenges and solutions.
    Reisberg S; Krebs K; Lepamets M; Kals M; Mägi R; Metsalu K; Lauschke VM; Vilo J; Milani L
    Genet Med; 2019 Jun; 21(6):1345-1354. PubMed ID: 30327539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel machine learning-based approach for the computational functional assessment of pharmacogenomic variants.
    Pandi MT; Koromina M; Tsafaridis I; Patsilinakos S; Christoforou E; van der Spek PJ; Patrinos GP
    Hum Genomics; 2021 Aug; 15(1):51. PubMed ID: 34372920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Computational Tools to Assess the Functional Consequences of Rare and Noncoding Pharmacogenetic Variability.
    Zhou Y; Lauschke VM
    Clin Pharmacol Ther; 2021 Sep; 110(3):626-636. PubMed ID: 33998671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Applying Multiplex Assays to Understand Variation in Pharmacogenes.
    Chiasson M; Dunham MJ; Rettie AE; Fowler DM
    Clin Pharmacol Ther; 2019 Aug; 106(2):290-294. PubMed ID: 31145826
    [No Abstract]   [Full Text] [Related]  

  • 10. Interpreting and Implementing Clinical Pharmacogenetic Tests: Perspectives From Service Providers.
    Hachad H; Ramsey LB; Scott SA
    Clin Pharmacol Ther; 2019 Aug; 106(2):298-301. PubMed ID: 31162629
    [No Abstract]   [Full Text] [Related]  

  • 11. Genomic testing is best integrated into clinical practice when it is actionable.
    Hendricks-Sturrup RM; Linsky A; Lu CY; Vassy JL
    Per Med; 2020 Jan; 17(1):5-8. PubMed ID: 31795838
    [No Abstract]   [Full Text] [Related]  

  • 12. Opportunities, resources, and techniques for implementing genomics in clinical care.
    Manolio TA; Rowley R; Williams MS; Roden D; Ginsburg GS; Bult C; Chisholm RL; Deverka PA; McLeod HL; Mensah GA; Relling MV; Rodriguez LL; Tamburro C; Green ED
    Lancet; 2019 Aug; 394(10197):511-520. PubMed ID: 31395439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An analysis of allele, genotype and phenotype frequencies, actionable pharmacogenomic (PGx) variants and phenoconversion in 5408 Australian patients genotyped for CYP2D6, CYP2C19, CYP2C9 and VKORC1 genes.
    Mostafa S; Kirkpatrick CMJ; Byron K; Sheffield L
    J Neural Transm (Vienna); 2019 Jan; 126(1):5-18. PubMed ID: 30191366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An optimized prediction framework to assess the functional impact of pharmacogenetic variants.
    Zhou Y; Mkrtchian S; Kumondai M; Hiratsuka M; Lauschke VM
    Pharmacogenomics J; 2019 Apr; 19(2):115-126. PubMed ID: 30206299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advancing Pharmacogenomics from Single-Gene to Preemptive Testing.
    Haidar CE; Crews KR; Hoffman JM; Relling MV; Caudle KE
    Annu Rev Genomics Hum Genet; 2022 Aug; 23():449-473. PubMed ID: 35537468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of pharmacokinetic gene profiles across human cancers.
    Zimmermann MT; Therneau TM; Kocher JA
    BMC Cancer; 2018 May; 18(1):577. PubMed ID: 29783934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Semantically enabling pharmacogenomic data for the realization of personalized medicine.
    Samwald M; Coulet A; Huerga I; Powers RL; Luciano JS; Freimuth RR; Whipple F; Pichler E; Prud'hommeaux E; Dumontier M; Marshall MS
    Pharmacogenomics; 2012 Jan; 13(2):201-12. PubMed ID: 22256869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Projected Prevalence of Actionable Pharmacogenetic Variants and Level A Drugs Prescribed Among US Veterans Health Administration Pharmacy Users.
    Chanfreau-Coffinier C; Hull LE; Lynch JA; DuVall SL; Damrauer SM; Cunningham FE; Voight BF; Matheny ME; Oslin DW; Icardi MS; Tuteja S
    JAMA Netw Open; 2019 Jun; 2(6):e195345. PubMed ID: 31173123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacogenomics in the age of personalized medicine.
    Dickmann LJ; Ware JA
    Drug Discov Today Technol; 2016; 21-22():11-16. PubMed ID: 27978982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unraveling the Genomic Architecture of the CYP3A Locus and ADME Genes for Personalized Tacrolimus Dosing.
    Yoon JG; Song SH; Choi S; Oh J; Jang IJ; Kim YJ; Moon S; Kim BJ; Cho Y; Kim HK; Min S; Ha J; Shin HS; Yang CW; Yoon HE; Yang J; Lee MG; Park JB; Kim MS;
    Transplantation; 2021 Oct; 105(10):2213-2225. PubMed ID: 33654003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.